Alnylam Pharmaceuticals, Inc. - NASDAQ:ALNY - Comprehensive analysis
Free evaluation through quantitative algorithms Alnylam Pharmaceuticals, Inc. - NASDAQ:ALNY
Growth-Scoring Model Detail
Total Revenue Growth Over Prior Year | 23 | Market 96 Sector 77 |
Gross Profit Growth Over Prior Year | 26.8 | Market 93 Sector 81 |
EBITDA Growth Over Prior Year | 0 | Market 0 Sector 0 |
EBITA Growth Over Prior Year | 0 | Market 0 Sector 0 |
EBIT Growth Over Prior Year | 0 | Market 0 Sector 0 |
Earnings from Cont. Ops. Growth Over Prior Year | 0 | Market 0 Sector 0 |
Net Income Growth Over Prior Year | 0 | Market 0 Sector 0 |
Normalized Net Income Growth Over Prior Year | 0 | Market 0 Sector 0 |
Diluted EPS before Extra Growth Over Prior Year | 0 | Market 0 Sector 0 |
A/R Growth Over Prior Year | 23.6 | Market 90 Sector 82 |
Inventory Growth Over Prior Year | -11.93 | Market 9 Sector 13 |
PPE Net Growth Over Prior Year | -4.39 | Market 17 Sector 48 |
Total Assets Growth Over Prior Year | 10.71 | Market 83 Sector 68 |
Tangible Book Value Growth Over Prior Year | 0 | Market 0 Sector 0 |
Common Equity Growth Over Prior Year | 0 | Market 0 Sector 0 |
Cash from Ops. Growth Over Prior Year | 0 | Market 0 Sector 0 |
CAPEX Growth Over Prior Year | -44.9 | Market 3 Sector 26 |
Dividend per Share Growth Over Prior Year | 0 | Market 36 Sector 48 |
Levered Free Cash Flow Growth Over Prior Year | 92 | Market 91 Sector 81 |
Unlevered Free Cash Flow Growth Over Prior Year | 60 | Market 87 Sector 76 |
Profitability-Scoring Model Detail
Gross Margin % | 86 | Market 96 Sector 86 |
SG&A Margin % | 43.4 | Market 93 Sector 53 |
EBITDA Margin % | -5.35 | Market 1 Sector 28 |
EBITA Margin % | -7.87 | Market 1 Sector 29 |
EBIT Margin % | -7.87 | Market 1 Sector 31 |
Earnings from Cont. Ops Margin % | -12.37 | Market 3 Sector 32 |
Net Income Margin % | -12.37 | Market 3 Sector 32 |
Net Income Avail. for Common Margin % | -12.37 | Market 3 Sector 32 |
Normalized Net Income Margin % | -10.41 | Market 1 Sector 28 |
Levered Free Cash Flow Margin % | 8.8 | Market 47 Sector 76 |
Unlevered Free Cash Flow Margin % | 12.75 | Market 55 Sector 80 |
Return on Assets % | -2.74 | Market 1 Sector 63 |
Return on Capital % | -4.19 | Market 1 Sector 62 |
Return on Equity % | 0 | Market 0 Sector 0 |
Return on Common Equity % | 0 | Market 0 Sector 0 |
Total Asset Turnover | 0.56 | Market 57 Sector 68 |
